On the concentration of 5-hydroxyindoleacetic acid in schizophrenia: A meta-analysis

Psychiatry Research

Volumn 59, Issue 3, 1996, Pages 239-244

  Tuckwell, Henry C ^a,c   Koziol, James A ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c CENTRE DE PHYSIQUE THÉORIQUE   (France)

Author keywords

Serotonin; Statistical analysis

Indexed keywords

5 HYDROXYINDOLEACETIC ACID;

AGE; ARTICLE; GENDER; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030043445     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(95)02741-6     Document Type: Article

References (32)

1. Ågren, H., Mefford, I.N., Rudorfer, M.V., Linnoila, M. and Potter, W.Z (1986) Interacting neurotransmitter systems: a non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res 20, 175-193.
2. Alfredsson, G. and Wiesel, F.A. (1989) Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology 99, 322-327.
3. Ashcroft, G.W. and Sharman, D. F. (1960) 5-Hydroxyindoles in human cerebrospinal fluids. Nature 186, 1050.
4. Berger, P.A., Faull, K.F., Kilkowski, J., Anderson, P.J., Kremer, H., Davis, K.L. and Barchas, J.D. (1980) CSF monoamine metabolites in depression and schizophrenia. Am J Psychiatry 137, 174-180.
5. Cooper, J.R., Bloom, F.E. and Roth, R.H. (1991) The Biochemical Basis of Neuropharmacology. Oxford University Press, New York.
6. Csernansky, J.G., King, R.J., Faustman, W.O., Moses, J.A., Jr., Poscher, M.E. and Faull, K.F. (1990) 5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristics. Br J Psychiatry 156, 501-507.
7. Davis, K.L., Kahn, R.S., Ko, G. and Davidson, M. (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148, 1474-1486.
8. Gattaz, W.F., Waldmeier, P. and Beckmann, H. (1982) CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand 66, 350-360.
9. Gerner, R.H., Fairbanks, L., Anderson, G.M., Young, J.G., Scheinin, M., Linnoila, M., Hare, T.A., Shaywitz, B.A. and Cohen, D.J. (1984) CSF neurochemistry in depressed, manic and schizophrenic patients, compared with that of normal controls. Am J Psychiatry 141, 1533-1540.
10. Haracz, J.L. (1982) The dopamine hypothesis: an overview of studies with schizophrenic patients. Schizophr Bull 8, 438-469.
11. Hedges, L.V. and Olkin, I. (1985) Statistical Methods for Meta-Analysis. Academic Press, New York.
12. Heritch, A.J. (1990) Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. Schizophr Bull 16, 605-615.
13. Hudson, C.J., Young, L.T. and Li, P.P. (1993) CNS signal transduction in the pathophysiology and pharmacotheraphy of affective disorders and schizophrenia. Synapse 13, 278-293.
14. Kahn, R.S., Siever, L.J., Gabriel, S., Amin, F., Stern, R.G., DuMont, K., Apter, S. and Davidson, M. (1992) Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects. Psychiatry Res 43, 1-12.
15. Karoum, F., Karson, C.N., Bigelow, L.B., Lawson, W.B. and Wyatt, R.J. (1987) Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia. Arch Gen Psychiatry 44, 604-607.
16. Koziol, J.A. and Tuckwell, H.C. (1994). A weighted procedure for combining independent tests. Biometrical Journal 36, 1005-1012.
17. Lewine, R.J.L., Risch, S.C., Risby, E., Stipetic, M., Jewart, R.D., Eccard, M., Caudle, J. and Pollard, W. (1991). Lateral ventricle-brain ratio and balance between CSF and 5-HIAA in schizophrenia. Am J Psychiatry 148, 1189-1194.
18. Lindström, L.H. (1985) Low HVA and normal 5-HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history. Psychiatry Res 14, 265-273.
19. Lindström, L.H., Wieselgren, I.-M., Klockhoff, I. and Svedberg, A. (1990) Relationship between abnormal and brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients. Biol Psychiatry 32, 1357-1361.
20. Maas, J.W. (1975) Biogenic amines and depression: biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry 32, 1357-1361.
21. McGeer, P.L., Eccles, J.C. and McGeer, E.G. (1987) Molecular Neurobiology of the Mammalian Brain. Plenum Press, New York.
22. Meltzer, H.Y. and Stahl, S.M. (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2, 19-76.
23. 2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology 106, 433-438.
24. Nybäck, H., Berggren, B.M., Hindmarsh, T., Sedvall, G. and Wiesel, F.-A. (1983) Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Res 9, 304-313.
25. Ohlund, L.S., Lindström, L.H. and Öhman, A. (1992) Electrodermal orienting response and central nervous system dopamine and serotonin activity in schizophrenia. J Nerv Ment Dis 180, 304-313.
26. Pickar, D., Breier, A., Hsiao, J.K., Doran, A.R., Wolkowitz, O.M., Pato, C.N., Konicki, E. and Potter, W.Z., (1990) Cerebrospinal fluid and plasma monoamine metabolites and their reaction to psychosis: implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry 47, 641-648.
27. Post, R.M., Fink, E., Carpenter, W.T. and Goodwin, F.K. (1975) Cerebrospinal fluid amine metabolites in acute schizophrenia. Arch Gen Psychiatry 32, 1063-1069.
28. Tuckwell, H.C. and Koziol, J.A. (1993) A meta-analysis of homovanillic acid concentrations in schizophrenia. Int J Neurosci 73, 109-114.
29. Van Horn, J.D. and McManus, I.C. (1992) Ventricular enlargement in schizophrenia. Br J Psychiatry 160, 687-695.
30. Widerlöv, E. (1988) A critical appraisal of CSF monoamine metabolite studies in schizophrenia. Ann NY Acad Sci 537, 309-323.
31. Winn, P. (1994) Schizophrenia research moves to the prefrontal cortex. Trends Neurosci 17, 265-268.
32. Woolley, D.W. and Shaw, E.-A. (1954) A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci (USA) 40, 228-231.